TLR9 and rheumatoid arthritis: A recent study showed that some enzoxazole derivatives act as TLR9 inhibitors with moderate to excellent activity in short term suppression of IL-6, suppression of IL-6 release from lymph nodes, indicating their potential as therapeutic agents for rheumatoid arthritis [29].